Fish Oil Enhances T Cell Function and Tumor Infiltration and Is Correlated With a Cancer Prevention Effect in HER-2/neu But Not PyMT Transgenic Mice

REFERENCES

• American Cancer Society: Cancer Facts & Figures. Atlanta: American Cancer Society, 2014.
   Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research: Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC, 2007.
   Google Scholar
• Vera-Ramirez L, Ramirez-Tortosa MC, Sanchez-Rovira P, Ramirez-Tortosa CL, and Granados-Principal S, et al.: Impact of diet on breast cancer risk: a review of experimental and observational studies. Crit Rev Food Sci Nutr 53, 49–75, 2013. doi:10.1080/10408398.2010.521600
   PubMed Web of Science ®Google Scholar
• Alexander DD, Morimoto LM, Mink PJ, and Lowe KA: Summary and meta-analysis of prospective studies of animal fat intake and breast cancer. Nutr Res Rev 23, 169–79, 2010. doi:10.1017/S095442241000003X
   PubMed Web of Science ®Google Scholar
• Zheng JS, Hu XJ, Zhao YM, Yang J, and Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346, f3706, 2013. doi:10.1136/bmj.f3706
   PubMed Web of Science ®Google Scholar
• Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, et al.: Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res 71, 6091–6096, 2011. doi:10.1158/0008-5472.CAN-11-0977
   PubMed Web of Science ®Google Scholar
• Shaikh SR, Jolly CA, and Chapkin RS: n-3 Polyunsaturated fatty acids exert immunomodulatory effects on lymphocytes by targeting plasma membrane molecular organization. Mol Aspects Med 33, 46–54, 2012. doi:10.1016/j.mam.2011.10.002
   PubMed Web of Science ®Google Scholar
• O'Connell EM, Schley PD, and Field CJ: Immune modulation and cancer resistance: enhancement by omega-3 fatty acids. In: Wildtype food in health promotion and disease prevention, De Meester F, & Watson RR (eds.). Totowa, NJ: The Columbus Concept. Humana Press, 2008, 285–307.
   Google Scholar
• da Rocha Junior LF, Dantas AT, Duarte AL, de Melo Rego MJ, Pitta Ida R, et al.: PPARgamma agonists in adaptive immunity: what do immune disorders and their models have to tell us? PPAR Res 2013, 519724, 2013. doi:10.1155/2013/519724
   PubMed Web of Science ®Google Scholar
• Swann JB and Smyth MJ: Immune surveillance of tumors. J Clin Invest 117, 1137–1146, 2007. doi:10.1172/JCI31405
   PubMed Web of Science ®Google Scholar
• Wallace ME and Smyth MJ: The role of natural killer cells in tumor control—effectors and regulators of adaptive immunity. Springer Semin Immunopathol 27, 49–64, 2005. doi:10.1007/s00281-004-0195-x
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF: Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther 9, 1043–1055, 2002. doi:10.1038/sj.cgt.7700540
   PubMed Web of Science ®Google Scholar
• Lanca T and Silva-Santos B: The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunology 1, 717–725, 2012. doi:10.4161/onci.20068
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, and Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073–1081, 2009. doi:10.1093/carcin/bgp127
   PubMed Web of Science ®Google Scholar
• Youn JI, Nagaraj S, Collazo M, and Gabrilovich DI: Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181, 5791–5802, 2008.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162–174, 2009. doi:10.1038/nri2506
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S and Sinha P: Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182, 4499–4506, 2009. doi: 10.4049/jimmunol.0802740
   PubMed Web of Science ®Google Scholar
• Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, and Clinton SK: Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr 135, 983–988, 2005.
   PubMed Web of Science ®Google Scholar
• Manni A, Xu H, Washington S, Aliaga C, Das A, et al.: The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice. Horm Cancer 2, 249–259, 2011. doi:10.1007/s12672-011-0078-2
   PubMedGoogle Scholar
• Guy CT, Cardiff RD, and Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12, 954–961, 1992.
   PubMed Web of Science ®Google Scholar
• Zaharoff DA, Rogers CJ, Hance KW, Schlom J, and Greiner JW: Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25, 2085–2094, 2007. doi:10.1016/j.vaccine.2006.11.034
   PubMed Web of Science ®Google Scholar
• Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, et al.: Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr 138, 115–122, 2008.
   PubMed Web of Science ®Google Scholar
• Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, et al.: Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine 26, 5407–5415, 2008. doi:10.1016/j.vaccine.2008.07.081
   PubMed Web of Science ®Google Scholar
• Yee LD, Agarwal D, Rosol TJ, Lehman A, Tian M, et al.: The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. Mol Nutr Food Res 57, 320–327, 2013. doi:10.1002/mnfr.201200445
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10, 181–193, 2010. doi:10.1038/nrc2809
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Sinha P, Beury DW, and Clements VK: Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 22, 275–281, 2012. doi:10.1016/j.semcancer.2012.01.011
   PubMed Web of Science ®Google Scholar
• Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, et al.: Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Cancer Immunol Immunother 59, 47–62, 2010. doi:10.1007/s00262-009-0719-2
   PubMed Web of Science ®Google Scholar
• Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, and Carson WE 3rd: Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res Treat 140, 13–21, 2013. doi:10.1007/s10549-013-2618-7
   PubMed Web of Science ®Google Scholar
• Ray A, Chakraborty K, and Ray P: Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front Cell Infect Microbiol 3, 52, 2013. doi:10.3389/fcimb.2013.00052
   PubMed Web of Science ®Google Scholar
• Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, et al.: Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181, 4666–4675, 2008.
   PubMed Web of Science ®Google Scholar
• Obermajer N, Wong JL, Edwards RP, Odunsi K, Moysich K, et al.: PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest 41, 635–657, 2012. doi:10.3109/08820139.2012.695417
   PubMed Web of Science ®Google Scholar
• Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S: Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70, 68–77, 2010. doi:10.1158/0008-5472.CAN-09-2587
   PubMed Web of Science ®Google Scholar
• Varney ME, Buchanan JT, Dementieva Y, Hardman WE, Sollars VE: A high omega-3 fatty acid diet has different effects on early and late stage myeloid progenitors. Lipids 46, 47–57, 2011. doi: 10.1007/s11745-010-3491-3
   PubMed Web of Science ®Google Scholar
• Yan D, Yang Q, Shi M, Zhong L, Wu C, et al.: Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway. Eur J Immunol 43, 2943–2955, 2013. doi:10.1002/eji.201343472
   PubMed Web of Science ®Google Scholar
• Soyland E, Nenseter MS, Braathen L, and Drevon CA: Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro. Eur J Clin Invest 23, 112–121, 1993.
   PubMed Web of Science ®Google Scholar
• Denys A, Hichami A, and Khan NA: n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res 46, 752–758, 2005. doi:10.1194/jlr.M400444-JLR200
   PubMed Web of Science ®Google Scholar
• Knutson KL and Disis ML: Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 54, 721–728, 2005. doi:10.1007/s00262-004-0653-2
   PubMed Web of Science ®Google Scholar
• Kim W, Khan NA, McMurray DN, Prior IA, Wang N, et al.: Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog Lipid Res 49, 250–261, 2010. doi:10.1016/j.plipres.2010.01.002
   PubMed Web of Science ®Google Scholar
• Cianci R, Pagliari D, Pietroni V, Landolfi R, and Pandolfi F: Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. J Biol Regul Homeost Agents 24, 239–249, 2010.
   PubMed Web of Science ®Google Scholar
• Jochems C and Schlom J: Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 236, 567–579, 2011. doi:10.1258/ebm.2011.011007
   PubMed Web of Science ®Google Scholar
• Schmid MC and Varner JA: Myeloid cells in tumor inflammation. Vasc Cell 4, 14, 2012. doi:10.1186/2045-824X-4-14
   Google Scholar
• Zeytin H, Reali E, Zaharoff DA, Rogers CJ, Schlom J, et al.: Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res 28, 73–87, 2008. doi:10.1089/jir.2007.0063
   PubMed Web of Science ®Google Scholar
• Gasteiger G and Rudensky AY: Interactions between innate and adaptive lymphocytes. Nat Rev Immunol 14, 631–639, 2014. doi:10.1038/nri3726
   PubMed Web of Science ®Google Scholar